Asociación de intolerancia a los antiinflamatorios no esteroideos, asma bronquial y pólipos nasales: aspectos clínicos y estrategias de tratamiento en Polonia

Autores/as

Palabras clave:

alergia, desensibilización, farmacoterapia, hipersensibilidad, marcadores diagnósticos

Resumen

Objetivo: Investigar la correlación entre la intolerancia a los antiinflamatorios no esteroideos (AINE), el asma bronquial y los pólipos nasales, y desarrollar una estrategia de tratamiento eficaz para pacientes que padecen estas afecciones simultáneamente.

Métodos: El estudio se llevó a cabo en varios centros clínicos; incluyó 200 pacientes diagnosticados con asma bronquial y pólipos nasales, e intolerancia a los AINE. Se recopilaron datos sobre las manifestaciones clínicas, incluyendo síntomas, frecuencia y gravedad de las exacerbaciones, junto con antecedentes alérgicos y la tolerancia a diversos fármacos. Además, se realizaron análisis de laboratorio, que incluyeron análisis de sangre para determinar los niveles de eosinófilos, inmunoglobulina E y otros marcadores inflamatorios.

Resultados: Se desarrollaron regímenes de tratamiento individualizados, que combinan farmacoterapia y métodos de desensibilización a los AINE. La farmacoterapia incluyó el uso de corticosteroides inhalados para reducir la inflamación de las vías respiratorias, antihistamínicos para controlar los síntomas alérgicos y anticuerpos monoclonales para modificar la respuesta inmunitaria. Los métodos de desensibilización implicaron la introducción gradual de AINE bajo estricta supervisión médica, lo que contribuyó a aumentar la tolerancia a estos fármacos.

Conclusiones: Este enfoque integral e individualizado mejoró significativamente la calidad de vida de los pacientes, reduce la frecuencia y la gravedad de las exacerbaciones, mejora la función pulmonar y el bienestar general. Este estudio destaca la importancia de un enfoque integral para el diagnóstico y el tratamiento de pacientes con intolerancia a los AINE, asma bronquial y pólipos nasales, y la necesidad de mayor investigación en esta área.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

1. Bousquet J, Schünemann HJ, Togias A, Bachert C, Erhola M, Hellings PW, et al. Allergic Rhinitis and Its Impact on Asthma Working Group. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence [Internet]. J Allergy Clin Immunol. 2020; 145(1):70-80. DOI: https://doi.org/10.1016/j.jaci.2019.06.049

2. Pawankar R, Nagata M. Asia pacific association of allergy asthma and clinical immunology and workshop on eosinophils in allergy and related diseases [Internet]. Asia Pac Allergy. 2020; 10(2):e23. DOI: https://doi.org/10.5415/apallergy.2020.10.e23

3. Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma [Internet]. Lancet. 2018; 391(10122):783-800. DOI: https://doi.org/10.1016/s0140-6736(17)33311-1

4. Ryu G, Bae J-S, Kim JH, Kim EH, Lyu L, Chung Y-J, et al. Role of IL-17A in chronic rhinosinusitis with nasal polyp [Internet]. Allergy, Asthma Immunol Res. 2020; 12(3):507-522. DOI: https://doi.org/10.4168/aair.2020.12.3.507

5. Weiss SL, Smith DM. A case of serum sickness-like reaction in an adult treated with omalizumab [Internet]. Mil Med. 2020; 185(5-6):912-913. DOI: https://doi.org/10.1093/milmed/usz357

6. Khan DA, Banerji A, Blumenthal KG, Phillips EJ, Solensky R, White AA, el al. Drug allergy: A 2022 practice parameter update [Internet]. J Allergy Clin Immunol. 2022; 150(6):1333-1393. DOI: https://doi.org/10.1016/j.jaci.2022.08.028

7. Diver S, Russell RJ, Brightling CE. New and emerging drug treatments for severe asthma [Internet]. Clin Exp Allergy. 2018; 48(3):241-252. DOI: https://doi.org/10.1111/cea.13086

8. Hansbro NG, Horvat JC, Wark PA, Hansbroa PM. Understanding the mechanisms of viral induced asthma: New therapeutic directions [Internet]. Pharmacol Ther. 2008; 117(3):313-353. DOI: https://doi.org/10.1016/j.pharmthera.2007.11.002

9. Diamant Z, van Maaren M, Muraro A, Jesenak M, Striz I. Allergen immunotherapy for allergic asthma: The future seems bright [Internet]. Respir Med. 2023; 210:107125. DOI: https://doi.org/10.1016/j.rmed.2023.107125

10. Pawankar R, Canonica GW, Holgate ST, Lockey RF. Allergic diseases and asthma: A major global health concern [Internet]. Curr Opin Allergy Clin Immunol. 2012; 12(1):39-41. DOI: https://doi.org/10.1097/aci.0b013e32834ec13b

11. Cheng S-L. Immunologic pathophysiology and airway remodeling mechanism in severe asthma: Focused on IgE-mediated pathways [Internet]. Diagnostics. 2021; 11(1):83. DOI: https://doi.org/10.3390/diagnostics11010083

12. Woo S-D, Yang E-M, Jang J, Lee Y, Shin YS, Ye Y-M, et al. Serum-free immunoglobulin E: A useful biomarker of atopy and type 2 asthma in adults with asthma [Internet]. Ann Allergy, Asthma, Immunol. 2021; 127(1):109-115. DOI: https://doi.org/10.1016/j.anai.2021.03.023

13. Wellmann N, Marc MS, Stoicescu ER, Pescaru CC, Trusculescu AA, Martis FG, et al. Enhancing adult asthma management: A review on the utility of remote home spirometry and mobile applications [Internet]. J Pers Med. 2024; 14(8):852. DOI: https://doi.org/10.3390/jpm14080852

14. Galant SP, Morphew T. Adding oscillometry to spirometry in guidelines better identifies uncontrolled asthma, future exacerbations, and potential targeted therapy [Internet]. Ann Allergy, Asthma, Immunol. 2024; 132(1):21-29. DOI: https://doi.org/10.1016/j.anai.2023.08.011

15. Burchett JR, Dailey JM, Kee SA, Pryor DT, Kotha A, Kankaria RA, et al. Targeting mast cells in allergic disease: Current therapies and drug repurposing [Internet]. Cells. 2022; 11(19):3031. DOI: https://doi.org/10.3390/cells11193031

16. Chacón P, Vega‐Rioja A, Doukkali B, del Valle Rodríguez A, Bellido V, Puente Y, et al. Targeted inhibition of allergen‐induced histamine production by neutrophils [Internet]. Fed Am Soc Exp Biol J. 2021; 35(5):e21483. DOI: https://doi.org/10.1096/fj.202001912R

17. Kotoulas SC, Tsiouprou I, Fouka E, Pataka A, Papakosta D, Porpodis K. Omalizumab: An optimal choice for patients with severe allergic asthma [Internet]. J Pers Med. 2022; 12(2):165. DOI: https://doi.org/10.3390/jpm12020165

18. Gon Y, Maruoka S, Mizumura K. Omalizumab and IgE in the control of severe allergic asthma [Internet]. Front Pharmacol. 2022; 13:839011. DOI: https://doi.org/10.3389/fphar.2022.839011

19. Hammad H, Lambrecht BN. The basic immunology of asthma [Internet]. Cell. 2021; 184(6):1469-85. DOI: https://doi.org/10.1016/j.cell.2021.02.016

20. Dastghaib S, Kumar PS, Aftabi S, Damera G, Dalvand A, Sepanjnia A, et al. Mechanisms targeting the unfolded protein response in asthma [Internet]. Am J Respir Cell Mol Biol. 2021; 64(1):29-38. DOI: https://doi.org/10.1165/rcmb.2019-0235TR

21. Pavón-Romero GF, Parra-Vargas MI, Ramírez-Jiménez F, Melgoza-Ruiz E, Serrano-Pérez NH, Teran LM. Allergen immunotherapy: Current and future trends [Internet]. Cells. 2022; 11(2):212. DOI: https://doi.org/10.3390/cells11020212

22. Hulett AC, Novo MJS, Martínez J, García ME, Rodríguez C, Torres J, et al. Asthma in Venezuela: An epidemiological narrative [Internet]. Gac Med Carac. 2025; 133(1):263-271. DOI: https://doi.org/10.47307/GMC.2025.133.1.24

23. Lambrecht BN, Hammad H. The immunology of the allergy epidemic and the hygiene hypothesis [Internet]. Nat Immunol. 2017; 18(10):1076-1083. DOI: https://doi.org/10.1038/ni.3829

24. Tyler MA, Luong AU. Current understanding of allergic fungal rhinosinusitis [Internet]. World J Otorhinolaryngol Head Neck Surg. 2018; 4(3):179-185. DOI: https://doi.org/10.1016/j.wjorl.2018.08.003

25. Van Wicklin SA. Safe and Effective Use of Local Anesthetics [Internet]. Plast Aesthetic Nurs. 2024; 44(3):172-179. DOI: https://doi.org/10.1097/PSN.0000000000000580

26. Ismailov I, Kılınç N, Magarde BK, Musheer M, Ahmad S. A systematic review of the role of surfactants in bronchial asthma: Implications for pathogenesis and treatment of the disease [Internet]. Gac Med Carac. 2024; 132:S152-S159. DOI: https://doi.org/10.47307/gmc.2024.132.s1.20

27. Yermukhanova LS, Urazaeva S, Artukbaeva M, Azhenova K, Almakhanova M, Zhaubassova A, et al. Determination of the air pollution index of atmospheric air in Aktobe [Internet]. Ann Trop Med Publ Health. 2017; 10(3):664-666. DOI: https://doi.org/10.4103/ATMPH.ATMPH_209_17

28. Kardas G, Panek M, Kuna P, Damiański P, Kupczyk M. Monoclonal antibodies in the management of asthma: Dead ends, current status and future perspectives [Internet]. Front Immunol. 2022; 13:983852. DOI: https://doi.org/10.3389/fimmu.2022.983852

29. Akdis CA, Bachert C, Cingi C, Dykewicz MS, Hellings PW, Naclerio RM, et al. Endotypes and phenotypes of chronic rhinosinusitis: A PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology [Internet]. J Allergy Clin Immunol [access: 07/12/2024]. 2020; 145(3):775-793. Available from: https://pubmed.ncbi.nlm.nih.gov/23587334/

30. Hartmane I, Ivdra I, Mikazans I, Bondare-Ansberga V. Immunopathogenic Treatment Options for Psoriasis Patients under a Restrictive Reimbursement Environment [Internet]. Proceed Latv Acad Sci Sect B Nat Exact Appl Sci. 2021; 75(3):158-166. DOI: https://doi.org/10.2478/prolas-2021-0025

31. Pashkovska O. ABCD Classification of Skin Types [Internet]. Plast Aesthetic Nurs. 2024; 44(3):188-199. DOI: https://doi.org/10.1097/PSN.0000000000000567

32. Hartmane I, Mikaþâns I, Ivdra I, Bondare-Ansberga V, Teterina I, Bataraga E. Retrospective cohort study comparing efficacy and safety of pharmacological intervention and phototherapy in moderate to severe psoriasis patients in a real-world setting [Internet]. Proceed Latv Acad Sci Sect B Nat Exact Appl Sci. 2024; 78(2):141-146. DOI: https://doi.org/10.2478/prolas-2024-0021

33. Price D, Castro M, Bourdin A, Fucile S, Altman P. Short-course systemic corticosteroids in asthma: Striking the balance between efficacy and safety [Internet]. Eur Respir Rev. 2020; 29(155):190151. DOI: https://doi.org/10.1183/16000617.0151-2019

34. Zasorin BV, Kurmangaliev OM, Ermukhanova LS. Features of the immune status in the population of urban areas with a high content of heavy metals [Internet]. Gig Sanit [access: 02/11/2024]. 2012; 3:17-19. Available from: https://pubmed.ncbi.nlm.nih.gov/23088112/

35. Balayeva EZ, Suleymanov TA, Hanaee J, Jouyban A. Liquid chromatographic determination of thymol in a pharmaceutical formulation [Internet]. Latin Amer J Pharm [access: 07/09/2024]. 2020; 39(8):1509-1514. Available from: https://www.researchgate.net/publication/353212213

Publicado

21.08.2025

Cómo citar

1.
Lisiecka MZ. Asociación de intolerancia a los antiinflamatorios no esteroideos, asma bronquial y pólipos nasales: aspectos clínicos y estrategias de tratamiento en Polonia. Rev Cubana Med Milit [Internet]. 21 de agosto de 2025 [citado 22 de agosto de 2025];54(3):e025076514. Disponible en: https://revmedmilitar.sld.cu/index.php/mil/article/view/76514

Número

Sección

Artículo de Investigación